| 股票 | 标签 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 博迅生物 920504 | 中性 | 医疗器械 | 45.4 | — | — | 4.03 | 1.1% | 59% | 40% | 19% | 0.8 | 1.1% | -6% | +37% | -21% | — | — | — | 8 |
| 辰光医疗 920300 | 亏损或困境 | 医疗器械 | — | — | — | 5.63 | — | — | 40% | 31% | — | -0.4% | -22% | +32% | -34% | — | — | — | 9 |
| 鹿得医疗 920278 | 中性 | 医疗器械 | 88.0 | — | — | 2.97 | 1.5% | 63% | 25% | 30% | 1.9 | -2.6% | -4% | +27% | -26% | — | — | — | 11 |
| 中科美菱 920992 | 纯久期 | 医疗器械 | 64.6 | 52.0 | 4.00 | 1.84 | 0.8% | 46% | 36% | 12% | 0.2 | 2.4% | -9% | +28% | -31% | — | — | — | 12 |
| 锦好医疗 920925 | 中性 | 医疗器械 | 715.2 | — | — | 3.29 | 0.4% | 50% | 46% | 25% | 0.7 | 0.2% | +16% | +174% | -62% | — | — | — | 12 |
| *ST益通 300430 | 亏损或困境 | 医疗器械 | — | — | — | 0.96 | — | 14% | 42% | 25% | — | -15.8% | -22% | +26% | -76% | -80% | -86% | 67% | 13 |
| 港通医疗 301515 | 亏损或困境 | 医疗器械 | — | — | — | 1.59 | — | 96% | 27% | 7% | — | -2.2% | -2% | +12% | -4% | -18% | -40% | 44% | 19 |
| 阳普医疗 300030 | 亏损或困境 | 医疗器械 | 70.1 | — | — | 3.24 | — | — | 41% | 37% | 1.0 | 5.8% | -12% | +33% | -7% | -23% | -33% | 37% | 21 |
| 爱朋医疗 300753 | 亏损或困境 | 医疗器械 | — | 156.0 | 11.14 | 4.19 | — | 87% | 66% | 20% | 6.9 | 1.1% | +2% | +58% | -21% | -40% | -58% | 69% | 28 |
| 东星医疗 301290 | 亏损或困境 | 医疗器械 | — | 23.7 | 0.35 | 1.31 | 1.1% | 62% | 49% | 14% | 1.2 | 1.6% | -4% | +12% | +12% | +4% | -36% | 39% | 28 |
| 麦澜德 688273 | 中性 | 医疗器械 | 38.0 | 25.3 | 1.69 | 2.15 | 2.7% | 78% | 71% | 28% | 0.4 | -0.1% | +5% | +90% | -32% | -36% | -54% | 62% | 29 |
| 汉邦科技 688755 | 中性 | 医疗器械 | 39.7 | — | — | 2.35 | 0.6% | 29% | 39% | 15% | 0.0 | 2.7% | +15% | — | -13% | -35% | -47% | 33% | 30 |
| 祥生医疗 688358 | 现金流红利 | 医疗器械 | 27.3 | 22.2 | 1.11 | 2.31 | 3.1% | 79% | 59% | 9% | 0.0 | 2.4% | +5% | +30% | -3% | -15% | -37% | 50% | 32 |
| 戴维医疗 300314 | 中性 | 医疗器械 | 55.2 | — | — | 2.70 | 0.7% | 35% | 58% | 25% | 0.0 | 1.6% | +5% | +13% | -8% | -25% | -40% | 42% | 33 |
| 康众医疗 688607 | 亏损或困境 | 医疗器械 | — | 178.6 | 2.03 | 4.07 | — | 31% | 40% | 15% | — | -2.5% | +16% | +224% | -10% | +32% | -54% | 69% | 34 |
| 乐心医疗 300562 | 中性 | 医疗器械 | 39.1 | — | — | 3.47 | 0.7% | 95% | 31% | 14% | 0.4 | 3.9% | -2% | -9% | +35% | +10% | -30% | 42% | 39 |
| 宝莱特 300246 | 亏损或困境 | 医疗器械 | — | — | — | 3.78 | 0.3% | — | 30% | 38% | 16.2 | 2.2% | -3% | +24% | +85% | +59% | -36% | 71% | 40 |
| 澳华内镜 688212 | 亏损或困境 | 医疗器械 | — | 96.0 | 0.79 | 3.40 | — | 85% | 69% | 33% | 7.7 | -2.3% | +20% | +9% | -29% | -39% | -51% | 39% | 42 |
| 伟思医疗 688580 | 中性 | 医疗器械 | 25.1 | 24.5 | 2.72 | 2.51 | 2.4% | 75% | 72% | 25% | 0.0 | 0.4% | +13% | +82% | -6% | -19% | -36% | 54% | 42 |
| 山外山 688410 | 成长兑现 | 医疗器械 | 24.2 | 16.6 | 0.50 | 2.47 | 1.4% | 45% | 45% | 20% | 0.0 | 0.5% | +28% | +36% | -5% | -13% | -27% | 42% | 45 |
| 康泰医学 300869 | 亏损或困境 | 医疗器械 | — | — | — | 2.73 | — | 73% | 49% | 11% | — | -0.1% | -13% | +10% | -25% | -40% | -44% | 29% | 45 |
| 瑞迈特 301367 | 中性 | 医疗器械 | 26.4 | 16.3 | 0.65 | 1.90 | 1.0% | 23% | 46% | 1% | 0.6 | 2.3% | -6% | +37% | -24% | -32% | -44% | 47% | 58 |
| 楚天科技 300358 | 中性 | 医疗器械 | 14.7 | — | — | 1.08 | 0.8% | 17% | 32% | 21% | 1.6 | 12.9% | -4% | +43% | -13% | -4% | -38% | 48% | 60 |
| 翔宇医疗 688626 | 中性 | 医疗器械 | 77.8 | 65.5 | 2.52 | 3.05 | 0.4% | 36% | 67% | 43% | 4.6 | -0.5% | +16% | +108% | -34% | -35% | -54% | 57% | 64 |
| 华康洁净 301235 | 中性 | 医疗器械 | 58.0 | 24.3 | 0.53 | 3.41 | 0.3% | 10% | 37% | 10% | 5.2 | -3.4% | +24% | +84% | +28% | +39% | -56% | 81% | 65 |
| 麦克奥迪 300341 | 中性 | 医疗器械 | 35.1 | — | — | 3.35 | 0.5% | 21% | 43% | 17% | 0.1 | 0.6% | -5% | -6% | -20% | -28% | -42% | 38% | 67 |
| 理邦仪器 300206 | 中性 | 医疗器械 | 19.4 | — | — | 3.09 | 2.6% | 59% | 57% | 24% | 0.1 | 5.0% | +5% | +17% | -6% | -8% | -28% | 40% | 68 |
| 超研股份 301602 | 纯久期 | 医疗器械 | 63.7 | — | — | 5.18 | 0.9% | 34% | 69% | 8% | — | 1.4% | +6% | — | -25% | -43% | -50% | 38% | 69 |
| 天智航 688277 | 亏损或困境 | 医疗器械 | — | — | — | 5.79 | — | — | 69% | 26% | — | -2.3% | +21% | +52% | -2% | -26% | -47% | 60% | 69 |
| 健信超导 688805 | 纯久期 | 医疗器械 | 75.1 | 88.1 | 3.83 | 5.68 | 0.7% | 50% | 26% | 10% | 0.0 | -0.6% | +17% | — | -1% | — | -40% | 63% | 69 |
| 万东医疗 600055 | 亏损或困境 | 医疗器械 | — | — | — | 1.76 | — | 54% | 42% | 6% | — | -3.1% | +6% | +4% | -30% | -39% | -46% | 30% | 76 |
| 新华医疗 600587 | 中性 | 医疗器械 | 18.0 | 12.0 | 1.20 | 0.97 | 2.8% | 35% | 26% | 21% | 1.2 | 7.2% | +2% | -11% | -11% | -24% | -32% | 26% | 77 |
| 开立医疗 300633 | 中性 | 医疗器械 | 52.3 | 27.9 | 0.82 | 2.85 | 0.9% | 30% | 67% | 27% | 1.1 | -0.4% | +9% | -10% | -23% | -40% | -51% | 35% | 86 |
| 三诺生物 300298 | 成长兑现 | 医疗器械 | 66.9 | 22.7 | 0.99 | 3.01 | — | 38% | 55% | 30% | 2.0 | 4.8% | +18% | -33% | -6% | -25% | -36% | 25% | 89 |
| 海尔生物 688139 | 中性 | 医疗器械 | 38.2 | 34.0 | 2.43 | 2.20 | 1.1% | 40% | 48% | 16% | 0.3 | 3.0% | -7% | -9% | -2% | -12% | -33% | 33% | 97 |
| 海泰新光 688677 | 中性 | 医疗器械 | 56.8 | 45.3 | 1.56 | 7.32 | 0.7% | 46% | 64% | 30% | 0.7 | 1.1% | +8% | +17% | +92% | +81% | -62% | 77% | 98 |
| 东富龙 300171 | 中性 | 医疗器械 | 41.0 | — | — | 1.35 | 0.8% | 30% | 35% | 16% | 0.2 | 3.6% | -2% | +19% | -10% | -8% | -41% | 39% | 107 |
| 福瑞医科 300049 | 纯久期 | 医疗器械 | 67.2 | 45.5 | 1.34 | 5.68 | 0.4% | 26% | 74% | 14% | 0.5 | 2.0% | +16% | +124% | -40% | -33% | -58% | 60% | 112 |
| 可孚医疗 301087 | 成长兑现 | 医疗器械 | 30.1 | 25.0 | 1.04 | 2.21 | 3.4% | 98% | 44% | 22% | 1.3 | 3.6% | +4% | +34% | +19% | +34% | -28% | 42% | 122 |
| 美好医疗 301363 | 中性 | 医疗器械 | 43.5 | 28.8 | 1.11 | 3.46 | 1.2% | 21% | 42% | 38% | 0.2 | 0.9% | +5% | +5% | -6% | -15% | -50% | 67% | 128 |
| 华大智造 688114 | 亏损或困境 | 医疗器械 | — | — | — | 3.43 | — | — | 56% | 24% | 4.1 | 1.0% | -13% | +30% | -5% | -22% | -42% | 56% | 241 |
| 鱼跃医疗 002223 | 定价权·品牌 | 医疗器械 | 23.0 | 16.7 | 1.04 | 1.94 | 4.6% | 44% | 50% | 11% | 0.0 | 5.4% | +4% | +7% | -31% | -29% | -45% | 30% | 259 |
| 奕瑞科技 688301 | 中性 | 医疗器械 | 39.4 | 29.5 | 0.98 | 3.68 | 0.7% | 31% | 55% | 48% | 3.0 | -3.9% | +13% | +50% | +27% | +14% | -45% | 54% | 284 |
| 联影医疗 688271 | 中性 | 医疗器械 | 50.6 | 39.1 | 1.56 | 4.06 | 0.3% | 13% | 48% | 19% | 0.7 | -0.1% | +14% | -0% | -13% | -20% | -38% | 34% | 895 |
| 迈瑞医疗 300760 | 定价权·品牌 | 医疗器械 | 26.2 | 23.9 | 1.71 | 5.08 | 2.5% | 65% | 64% | 18% | 0.0 | 4.4% | +3% | -24% | -10% | -30% | -45% | 28% | 2059 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。